SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$54.00
-1.88 (-3.36%)
As of Jun 30, 10:36 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -17.1% upside
Low Target $31.89
Average Target $44.79
High Target $48.55
Current Price $54.00
Current
$54.00
Target
$44.79
$31.89 $44.79 avg $48.55
Scenario Analysis
Bear Case
$31.89
-40.9%
Low target
Base Case
$44.79
-17.1%
Avg target
Bull Case
$48.55
+-10.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$240.00
-77.5% from high
52-Week Low
$4.77
+1,032.1% from low
Target vs 52W High
$44.79
-81.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%